Skip to main content

Table 7 Change in HbA1c values (with HbA1c denoted in mmol/mol) after sitagliptin titration

From: The effect of oral diabetes medications on glycated haemoglobin (HbA1c) in Asians in primary care: a retrospective cohort real-world data study

Sitagliptin dose after titration

0

25

50

75

100

 

-8(-9, -6)#m=266

-8(-9, -7)#m=411

 

-6(-9, -2)#m=86

8(6, 9)#m=93

 

-3(-4, -2)#m=225

  

8(6, 10)#m=156

3(0, 6)#m=56

 

-3(-7, 0)#m=43

-2(-4, -1)#m=439

    

1(-3, 6)#m=35

7(4, 9)#m=82

 

2(0, 3)#m=91

  
  1. Change in HbA1c values after sitagliptin initiation, titration, or discontinuation. The values above the diagonal represent the instances where the medication has been initiated or up-titrated, while the values below the diagonal represent instances where the medication has been down-titrated or discontinued. The values refer to the mean difference in HbA1c (MD) and 95% confidence intervals. MD below 0 indicate a lowering in HbA1c while those above 0 indicate an increase in HbA1c. #m refers to the number of HbA1c pairs for that dose titration